Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
New angiogenesis research from M. Chakra et al outlined
December 9th, 2008
According to a study from Montpellier, France, "High circulating serum vascular endothelial growth factor (VEGF) levels might reflect enhanced angiogenesis in patients suffering from non-small cell lung cancer (NSCLC). This Study aimed at determining the prognostic significance of circulating VEGF as a prognostic factor in NSCLC." "Four hundred fifty-one histologically or cytologically proven and previously untreated NSCLC patients have been Studied. Median follow-up was 13 years and 9 months. Eleven clinical and biologic variables were recorded. The levels of circulating VEGF were measured in the serum by quantitative irnmunoassay. Patients have had received...
Source: Cancer Weekly (2008-12-09)
|
